104 related articles for article (PubMed ID: 38941700)
1. Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson's disease.
de Freitas Silva M; Juliet Cristancho Ortiz C; Ferreira Coelho L; Pruccoli L; Pagliarani B; Pisani L; Catto M; Poli G; Tuccinardi T; Cardoso Vilela F; Giusti-Paiva A; Amaral Alves M; Ribeiro de Souza HM; Tarozzi A; Silva Gontijo V; Viegas C
Bioorg Chem; 2024 Jun; 150():107587. PubMed ID: 38941700
[TBL] [Abstract][Full Text] [Related]
2. Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
Ortiz CJC; Damasio CM; Pruccoli L; Nadur NF; de Azevedo LL; Guedes IA; Dardenne LE; Kümmerle AE; Tarozzi A; Viegas C
Neurochem Res; 2020 Dec; 45(12):3003-3020. PubMed ID: 33079324
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer's disease.
Macedo Vaz S; de Freitas Silva M; Dos Reis Rosa Franco G; Jorge R Guimarães M; Motta R da Silva F; Gonçalves Castro N; Alvim Guedes I; Dardenne LE; Amaral Alves M; Garrett da Costa R; Beserra Pinheiro G; Germino Veras L; Renata Mortari M; Pruccoli L; Tarozzi A; Viegas C
Bioorg Med Chem; 2022 Oct; 71():116952. PubMed ID: 35930852
[TBL] [Abstract][Full Text] [Related]
4. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Modulates p62-Keap1-Nrf2-Mediated Autophagy in Rotenone-Induced Parkinson's Disease Mouse Models.
Rathore AS; Singh SS; Birla H; Zahra W; Keshri PK; Dilnashin H; Singh R; Singh S; Singh SP
ACS Chem Neurosci; 2023 Mar; ():. PubMed ID: 36989171
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of Novel Triazole
de Freitas Silva M; Tardelli Lima E; Pruccoli L; Castro NG; Guimarães MJR; M R da Silva F; Fonseca Nadur N; de Azevedo LL; Kümmerle AE; Guedes IA; Dardenne LE; Gontijo VS; Tarozzi A; Viegas C
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664425
[No Abstract] [Full Text] [Related]
7. A synthetic resveratrol-curcumin hybrid derivative exhibits chemopreventive effects on colon pre-neoplastic lesions by targeting Wnt/β-catenin signaling, anti-inflammatory and antioxidant pathways.
Baptistella MM; Assunção RRS; Sales de Oliveira C; Siqueira AP; Gonçalves Dos Santos E; de Freitas Silva M; Lima ETF; Caixeta ES; Novaes RD; Ferreira EB; Ionta M; Viegas C; Francielli de Oliveira P
J Pharm Pharmacol; 2024 May; 76(5):479-488. PubMed ID: 37874746
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
[TBL] [Abstract][Full Text] [Related]
9. Effect of Diacetylcurcumin Manganese Complex on Rotenone-Induced Oxidative Stress, Mitochondria Dysfunction, and Inflammation in the SH-SY5Y Parkinson's Disease Cell Model.
Pirunkaset E; Boonyarat C; Maneenet J; Khamphukdee C; Daodee S; Monthakantirat O; Awale S; Kijjoa A; Chulikhit Y
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474469
[TBL] [Abstract][Full Text] [Related]
10. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
11. Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
Wang L; Cai X; Shi M; Xue L; Kuang S; Xu R; Qi W; Li Y; Ma X; Zhang R; Hong F; Ye H; Chen L
Eur J Med Chem; 2020 Aug; 199():112385. PubMed ID: 32402936
[TBL] [Abstract][Full Text] [Related]
12. Lignans from Eucommia ulmoides Oliver leaves exhibit neuroprotective effects via activation of the PI3K/Akt/GSK-3β/Nrf2 signaling pathways in H
Han R; Yu Y; Zhao K; Wei J; Hui Y; Gao JM
Phytomedicine; 2022 Jul; 101():154124. PubMed ID: 35487038
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation.
Cristancho Ortiz CJ; de Freitas Silva M; Pruccoli L; Fonseca Nadur N; de Azevedo LL; Kümmerle AE; Guedes IA; Dardenne LE; Leomil Coelho LF; Guimarães MJ; da Silva FMR; Castro N; Gontijo VS; Rojas VCT; de Oliveira MK; Vilela FC; Giusti-Paiva A; Barbosa G; Lima LM; Pinheiro GB; Veras LG; Mortari MR; Tarozzi A; Viegas C
RSC Med Chem; 2022 May; 13(5):568-584. PubMed ID: 35694691
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
15. 2-Hydroxy-4-benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease.
Cao Z; Zhang T; Fu X; Wang X; Xia Q; Zhong L; Zhu J
ChemMedChem; 2023 Mar; 18(6):e202200629. PubMed ID: 36622947
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2/Keap1/SLC7A11 pathway in a microglia cell line.
Li H; Shen Y; Xiao H; Sun W
Pathol Res Pract; 2021 Sep; 225():153576. PubMed ID: 34391968
[TBL] [Abstract][Full Text] [Related]
17. A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model.
Lee JA; Kim JH; Woo SY; Son HJ; Han SH; Jang BK; Choi JW; Kim DJ; Park KD; Hwang O
Br J Pharmacol; 2015 Feb; 172(4):1087-100. PubMed ID: 25297649
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.
Anastassova N; Aluani D; Kostadinov A; Rangelov M; Todorova N; Hristova-Avakumova N; Argirova M; Lumov N; Kondeva-Burdina M; Tzankova V; Yancheva D
Neural Regen Res; 2021 Nov; 16(11):2299-2309. PubMed ID: 33818516
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection of Andrographolide against Neurotoxin MPP
Prasertsuksri P; Kraokaew P; Pranweerapaiboon K; Sobhon P; Chaithirayanon K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239873
[TBL] [Abstract][Full Text] [Related]
20. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
